Plus Therapeutics (PSTV)
(Delayed Data from NSDQ)
$1.17 USD
-0.09 (-7.14%)
Updated Nov 15, 2024 04:00 PM ET
After-Market: $1.18 +0.01 (0.85%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 3/4/25 |
---|---|
Current Quarter | -0.43 |
EPS Last Quarter | -0.46 |
Last EPS Surprise | 0.00% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.00 |
Next Year | -1.46 |
EPS (TTM) | -2.62 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.60M | 1.80M | 5.98M | 5.68M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 1.99M | 2.10M | 6.55M | 6.36M |
Low Estimate | 1.20M | 1.50M | 5.40M | 5.00M |
Year ago Sales | 1.31M | 1.68M | 4.91M | 5.98M |
Year over Year Growth Est. | 21.76% | 7.14% | 21.62% | -4.94% |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.43 | -0.31 | -2.00 | -1.46 |
# of Estimates | 2 | 2 | 1 | 2 |
Most Recent Consensus | -0.35 | -0.35 | -2.00 | -1.35 |
High Estimate | -0.35 | -0.30 | -2.00 | -1.35 |
Low Estimate | -0.51 | -0.32 | -2.00 | -1.56 |
Year ago EPS | -0.70 | -0.75 | -4.24 | -2.00 |
Year over Year Growth Est. | 38.57% | 58.67% | 52.83% | 27.25% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.43 | -0.31 | -2.00 | -1.46 |
7 Days Ago | -0.43 | -0.31 | -2.00 | -1.46 |
30 Days Ago | -0.43 | -0.31 | -2.00 | -1.46 |
60 Days Ago | -0.43 | -0.31 | -2.00 | -1.46 |
90 Days Ago | -0.51 | -0.30 | NA | -1.56 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.43 | -0.31 | -2.00 | -1.46 |
Zacks Consensus Estimate | -0.43 | -0.31 | -2.00 | -1.46 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.46 | -0.71 | -0.75 | -0.70 | NA |
Estimate | -0.46 | NA | NA | -0.78 | NA |
Difference | 0.00 | NA | NA | 0.08 | 0.04 |
Surprise | 0.00% | NA | NA | 10.26% | 5.13% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more